Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 1202 |
| Name of the vaccine | WRSS1 |
| Microbe | Bacteria |
| Disease name | Bacillary Dysentery (Shigellosis) |
| Name of bacteria | Shigella genus |
| Type of vaccine | Live attenuated |
| Nucleic acid content | DNA |
| Age | 20 to 40 years |
| Description of the vaccine | Shigella Sonnei vaccine. |
| Name of the manufacturer | U.S. Army Medical Research and Development Command |
| Name of the manufacturing country | Thailand |
| Year of manufacture | 2011 |
| Clinical Phase status | Clinical - Phase 1, Phase 2 |
| Bacterial strain | Gram-negative bacteria. |
| Efficacy | NA |
| Vaccine formulation | Lyophilized |
| Dosage | Single dose. |
| Mechanism of action | S. sonnei LPS-specific IgA antibody. |
| Route of administration | Oral |
| Indications | NA |
| Export | NA |
| Approval | NA |
| Adjuvant | NA |
| Repurposing | For Shigella and diarrhoea. |
| Side effects of vaccine | Loose stool, diarrhoea, dysentery, nausea, vomiting, abdominal pain and cramps, bloating, constipation, fever, chills, headache, light-headedness, generalized myalgia, malaise, decreased appetite, excess flatulence, reactive arthritis and arthralgia. |
| Post vaccination | NA |
| Dose type | Single dose |
| Interspecies transfer | NA |
| PubMed identifier | 30794051 |
| Clinical trial number | NCT01080716 |
| Reference | NA |
| Other name | NA |
| Additional Links | NA |